ReviewCurrent oncology (Toronto, Ont.)2022

HE4 Tissue Expression as A Putative Prognostic Marker in Low-Risk/Low-Grade Endometrioid Endometrial Cancer: A Review.

Valerio Mais et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.